These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30787391)

  • 1. Sirtuin 6 in preosteoclasts suppresses age- and estrogen deficiency-related bone loss by stabilizing estrogen receptor α.
    Moon YJ; Zhang Z; Bang IH; Kwon OK; Yoon SJ; Kim JR; Lee S; Bae EJ; Park BH
    Cell Death Differ; 2019 Nov; 26(11):2358-2370. PubMed ID: 30787391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalpol attenuates osteoporosis in ovariectomized rats through promoting osteoclast apoptosis via the Sirt6-ERα-FasL axis.
    Chen S; Jin J; Xu Z; Han H; Wu L; Li Z
    Phytomedicine; 2024 Jan; 123():155262. PubMed ID: 38100921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone.
    Martin-Millan M; Almeida M; Ambrogini E; Han L; Zhao H; Weinstein RS; Jilka RL; O'Brien CA; Manolagas SC
    Mol Endocrinol; 2010 Feb; 24(2):323-34. PubMed ID: 20053716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.
    Nakamura T; Imai Y; Matsumoto T; Sato S; Takeuchi K; Igarashi K; Harada Y; Azuma Y; Krust A; Yamamoto Y; Nishina H; Takeda S; Takayanagi H; Metzger D; Kanno J; Takaoka K; Martin TJ; Chambon P; Kato S
    Cell; 2007 Sep; 130(5):811-23. PubMed ID: 17803905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Aging and Sex Steroid Deficiency on the Murine Skeleton Are Independent and Mechanistically Distinct.
    Ucer S; Iyer S; Kim HN; Han L; Rutlen C; Allison K; Thostenson JD; de Cabo R; Jilka RL; O'Brien C; Almeida M; Manolagas SC
    J Bone Miner Res; 2017 Mar; 32(3):560-574. PubMed ID: 27714847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
    Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual targeting of SREBP2 and ERRα by carnosic acid suppresses RANKL-mediated osteoclastogenesis and prevents ovariectomy-induced bone loss.
    Zheng ZG; Cheng HM; Zhou YP; Zhu ST; Thu PM; Li HJ; Li P; Xu X
    Cell Death Differ; 2020 Jul; 27(7):2048-2065. PubMed ID: 31907393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency-induced bone mass loss by modulating TRAF6-mediated signaling.
    Hu B; Sun X; Yang Y; Ying Z; Meng J; Zhou C; Jiang G; Li S; Wu F; Zhao X; Zhu H; Wu H; Cai X; Shi Z; Yan S
    FASEB J; 2019 Feb; 33(2):2574-2586. PubMed ID: 30285579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic research on senile osteoporosis caused by SIRT6 deficiency.
    Zhang DM; Cui DX; Xu RS; Zhou YC; Zheng LW; Liu P; Zhou XD
    Int J Oral Sci; 2016 Jun; 8(2):84-92. PubMed ID: 27357320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorosis increases the risk of postmenopausal osteoporosis by stimulating interferon γ.
    Lv YG; Kang L; Wu G
    Biochem Biophys Res Commun; 2016 Oct; 479(2):372-379. PubMed ID: 27644876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirt6 deletion in hepatocytes increases insulin sensitivity of female mice by enhancing ERα expression.
    Tang C; Liu P; Zhou Y; Jiang B; Song Y; Sheng L
    J Cell Physiol; 2019 Aug; 234(10):18615-18625. PubMed ID: 30912134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice.
    Fujiwara Y; Piemontese M; Liu Y; Thostenson JD; Xiong J; O'Brien CA
    J Biol Chem; 2016 Nov; 291(48):24838-24850. PubMed ID: 27733688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas receptor is required for estrogen deficiency-induced bone loss in mice.
    Kovacic N; Grcevic D; Katavic V; Lukic IK; Grubisic V; Mihovilovic K; Cvija H; Croucher PI; Marusic A
    Lab Invest; 2010 Mar; 90(3):402-13. PubMed ID: 20084056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling estrogen action in osteoporosis.
    Krum SA; Brown M
    Cell Cycle; 2008 May; 7(10):1348-52. PubMed ID: 18418063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phlpp1 is induced by estrogen in osteoclasts and its loss in Ctsk-expressing cells does not protect against ovariectomy-induced bone loss.
    Hanson MK; Karkache IY; Molstad DHH; Norton AA; Mansky KC; Bradley EW
    PLoS One; 2021; 16(6):e0251732. PubMed ID: 34143773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen Deficiency-Mediated M2 Macrophage Osteoclastogenesis Contributes to M1/M2 Ratio Alteration in Ovariectomized Osteoporotic Mice.
    Dou C; Ding N; Zhao C; Hou T; Kang F; Cao Z; Liu C; Bai Y; Dai Q; Ma Q; Luo F; Xu J; Dong S
    J Bone Miner Res; 2018 May; 33(5):899-908. PubMed ID: 29281118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice.
    Lee EJ; Kim JL; Kim YH; Kang MK; Gong JH; Kang YH
    Phytomedicine; 2014 Sep; 21(10):1208-15. PubMed ID: 24932975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
    Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
    J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition.
    Sophocleous A; Marino S; Kabir D; Ralston SH; Idris AI
    Aging Cell; 2017 Oct; 16(5):1051-1061. PubMed ID: 28752643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.